v2.3.0.15
Consolidated Statements Of Operations (USD $)
In Thousands, except Per Share data
12 Months Ended
Sep. 30, 2011
Sep. 24, 2010
Sep. 25, 2009
Revenue:   
Licensing$ 790,340$ 710,474$ 594,697
Products131,611180,40295,967
Services33,55431,83728,839
Total revenue955,505922,713719,503
Cost of revenue:   
Cost of licensing17,62017,56514,803
Cost of products81,32890,69557,220
Cost of services12,22313,96112,786
Gain from amended patent licensing agreement  (20,041)
Impairment of products provided under operating leases 9,594 
Total cost of revenue111,171131,81564,768
Gross margin844,334790,898654,735
Operating expenses:   
Research and development123,920104,97881,543
Sales and marketing149,642130,16098,838
General and administrative137,633119,353105,841
Restructuring charges, net3,4067,0264,847
Total operating expenses414,601361,517291,069
Operating income429,733429,381363,666
Interest income8,9767,29811,265
Interest expense1,027(703)(935)
Other (expenses)/income, net9071,036(2,577)
Income before provision for income taxes440,643437,012371,419
Provision for income taxes(130,061)(154,185)(127,073)
Net income including controlling interest310,582282,827244,346
Less: net (income) / loss attributable to controlling interest(1,315)620(1,355)
Net income attributable to Dolby Laboratories, Inc.309,267283,447242,991
Net income per share:   
Basic$ 2.78$ 2.50$ 2.15
Diluted$ 2.75$ 2.46$ 2.11
Weighted-average shares outstanding:   
Basic111,444113,452113,101
Diluted112,554115,388115,367
Related party rent expense included in general and administrative expenses$ 1,372$ 1,372$ 1,272